These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24927736)

  • 41. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
    Garcia-Closas M; Kristensen V; Langerød A; Qi Y; Yeager M; Burdett L; Welch R; Lissowska J; Peplonska B; Brinton L; Gerhard DS; Gram IT; Perou CM; Børresen-Dale AL; Chanock S
    Int J Cancer; 2007 Dec; 121(11):2532-8. PubMed ID: 17683073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.
    Feigelson HS; Teras LR; Diver WR; Tang W; Patel AV; Stevens VL; Calle EE; Thun MJ; Bouzyk M
    Breast Cancer Res; 2008; 10(4):R57. PubMed ID: 18611262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.
    Elgazzar S; Zembutsu H; Takahashi A; Kubo M; Aki F; Hirata K; Takatsuka Y; Okazaki M; Ohsumi S; Yamakawa T; Sasa M; Katagiri T; Miki Y; Nakamura Y
    J Hum Genet; 2012 Dec; 57(12):766-71. PubMed ID: 22951594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
    Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
    Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
    Lei J; Rudolph A; Moysich KB; Behrens S; Goode EL; Bolla MK; Dennis J; Dunning AM; Easton DF; Wang Q; Benitez J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Fasching PA; Haeberle L; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marmé F; Guénel P; Truong T; Bojesen SE; Flyger H; Nielsen SF; Nordestgaard BG; González-Neira A; Menéndez P; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Fagerholm R; Dörk T; Bogdanova NV; Mannermaa A; Hartikainen JM; ; ; Van Dijck L; Smeets A; Flesch-Janys D; Eilber U; Radice P; Peterlongo P; Couch FJ; Hallberg E; Giles GG; Milne RL; Haiman CA; Schumacher F; Simard J; Goldberg MS; Kristensen V; Borresen-Dale AL; Zheng W; Beeghly-Fadiel A; Winqvist R; Grip M; Andrulis IL; Glendon G; García-Closas M; Figueroa J; Czene K; Brand JS; Darabi H; Eriksson M; Hall P; Li J; Cox A; Cross SS; Pharoah PD; Shah M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Ademuyiwa F; Ambrosone CB; Swerdlow A; Jones M; Chang-Claude J
    Hum Genet; 2016 Jan; 135(1):137-54. PubMed ID: 26621531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Breast Cancer Res Treat; 2011 Sep; 129(2):593-606. PubMed ID: 21516303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
    Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
    Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
    Hamdi Y; Soucy P; Adoue V; Michailidou K; Canisius S; Lemaçon A; Droit A; Andrulis IL; Anton-Culver H; Arndt V; Baynes C; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brenner H; Broeks A; Burwinkel B; Chang-Claude J; ; Couch FJ; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Devilee P; Dörk T; Dos-Santos-Silva I; Eriksson M; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Goldberg MS; González-Neira A; Grenaker-Alnæs G; Guénel P; Haeberle L; Haiman CA; Hamann U; Hallberg E; Hooning MJ; Hopper JL; Jakubowska A; Jones M; Kabisch M; Kataja V; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Maranian M; Margolin S; Marme F; Milne RL; Neuhausen SL; Nevanlinna H; Neven P; Olswold C; Peto J; Plaseska-Karanfilska D; Pylkäs K; Radice P; Rudolph A; Sawyer EJ; Schmidt MK; Shu XO; Southey MC; Swerdlow A; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Van Den Ouweland AM; Wang Q; Winqvist R; ; Zheng W; Benitez J; Chenevix-Trench G; Dunning AM; Pharoah PD; Kristensen V; Hall P; Easton DF; Pastinen T; Nord S; Simard J
    Oncotarget; 2016 Dec; 7(49):80140-80163. PubMed ID: 27792995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
    Gold B; Kirchhoff T; Stefanov S; Lautenberger J; Viale A; Garber J; Friedman E; Narod S; Olshen AB; Gregersen P; Kosarin K; Olsh A; Bergeron J; Ellis NA; Klein RJ; Clark AG; Norton L; Dean M; Boyd J; Offit K
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4340-5. PubMed ID: 18326623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
    Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
    Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
    Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.
    O'Brien KM; Cole SR; Poole C; Bensen JT; Herring AH; Engel LS; Millikan RC
    Am J Epidemiol; 2014 Feb; 179(3):382-94. PubMed ID: 24218030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.